COMMUNIQUÉS West-GlobeNewswire

Navamedic ASA: Invitation to presentation of third quarter results 2017

02/11/2017 - 09:48

Navamedic ASA invites you to follow an online presentation of the third quarter 2017 figures. The presentation will be webcasted at www.navamedic.com - investor relations - presentations - webcast on Friday 10.11 2017 [...]

Photocure ASA:U.S. CMS improves reimbursement for Blue Light Cystoscopy with Cysview®

02/11/2017 - 08:07

Oslo, Norway, November 2,2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has issued a Final Rule stating that it will reimburse hospital [...]

Notice to Attend the Extraordinary General Meeting of Immunicum

02/11/2017 - 07:40

Press Release 2 November 2017 Notice to Attend the Extraordinary General Meeting of Immunicum The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to an Extraordinary General [...]

Zealand reports royalty revenue for the third quarter of 2017

02/11/2017 - 07:39

Company announcement - No. 49/2017 Zealand reports royalty revenue for the third quarter of 2017 Zealand reports royalty revenue of DKK 10.3 million/USD 1.6 million for Q3 2017 The revenue is based on total net sales of [...]

Galapagos moving forward in CF programs at NACFC 2017

02/11/2017 - 07:30

Ten posters and four oral presentations reflect progress toward triple combination therapy Mechelen, Belgium; 2 November 2017; 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV ( [...]

The Board of Directors of Immunicum AB (publ) Resolves on a 90% Secured Rights Issue of up to SEK 223 Million to Finance Further Development of its Portfolio

02/11/2017 - 07:30

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED OR RELEASED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR [...]

Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed

02/11/2017 - 07:29

Paris, November 2, 2017 Q3 2017 Business EPS (1) up 1.1% at CER (2) FY 2017 Guidance Confirmed Q3 2017 Change Change at CER Change at CER/CS (3) 9M 2017 Change Change at CER Change at CER/CS (3) IFRS net sales reported [...]

Sanofi : Hausse de 1,1% du BNPA des activités à TCC au T3 2017 Perspectives 2017 confirmées

02/11/2017 - 07:29

Paris, le 2 novembre 2017 Hausse de 1,1% du BNPA des activités (1) à TCC (2) au T3 2017 Perspectives 2017 confirmées T3 2017 Var Var. (TCC) Var. à TCC/PC (3) 9M 2017 Var Var. (TCC) Var. à TCC/PC (3) Chiffre d'affaires [...]

Basilea reports on commercial progress of antifungal Cresemba® in Europe

02/11/2017 - 07:15

Cresemba launched by Pfizer in Spain and is now commercially available in all Top-5 EU markets Marketing authorization received for Switzerland Basel, Switzerland, November 2, 2017 - Basilea Pharmaceutica Ltd. (SIX: [...]

argenx to host KOL breakfast symposium on pemphigus vulgaris on November 10, 2017

02/11/2017 - 07:00

November 2, 2 017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

MDxHealth Nine Month Trading Update

02/11/2017 - 07:00

Patient test volume for the first nine months up 43% SelectMDx test volume in Europe increased nearly 400% NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, November [...]

Rapport d'activités des neuf premiers mois de MDxHealth

02/11/2017 - 07:00

Le volume des tests pour les patients a augmenté de 43 % les neuf premiers mois Le volume des tests SelectMDx en Europe a augmenté de près de 400 % COMMUNIQUÉ DE PRESSE / INFORMATION RÉGLEMENTÉE / INFORMATION [...]

TiGenix strengthens European IP protection around lead development program Cx601

02/11/2017 - 07:00

PRESS RELEASE TiGenix strengthens European IP protection around lead development program Cx601 Leuven (BELGIUM) - November 2, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced [...]

TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601

02/11/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601 Louvain (BELGIQUE) - 2 novembre 2017, 07h. CET - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]

Targovax ASA: Third quarter 2017 results

02/11/2017 - 07:00

Oslo, Norway, 2 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its third quarter 2017 results. A meeting for [...]

Orion Corporation: Managers' transactions - Hilpi Rautelin

01/11/2017 - 21:15

ORION CORPORATION MANAGERS' TRANSACTIONS 1 st of November 2017 at 22.15 EET Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse [...]

Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference

01/11/2017 - 21:05

DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Medtronic Unveils Strong Early Outcomes for the Intrepid(TM) Transcatheter Mitral Valve Replacement (TMVR) System

01/11/2017 - 19:15

First Report Investigation at TCT Published in JACC Shows Substantial Mitral Valve Regurgitation Reductions and Versatility of Dual-Stent Design DUBLIN and DENVER - November 1, 2017 - Medtronic plc (NYSE:MDT) today [...]

Independent Study Shows New Data on Shortened DAPT in STEMI Patients with Medtronic Resolute Integrity Drug-Eluting Stent

01/11/2017 - 18:20

DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI [...]